Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ Recombinant Human IL-19 Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Supplier:  R&D Systems™ 1035IL025

 View more versions of this product

Catalog No. 1035IL025


Explore available promotions
Add to Cart
This item is not returnable. View return policy

Description

Description

The Recombinant Human IL-19 Protein is derived from E. coli. The Recombinant Human IL-19 Protein has been validated for the following applications: Bioactivity.
Specifications

Specifications

Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein.
18 kDa (monomer)
25 μg
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
Recombinant
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
29949
IL-19
E. coli-derived human IL-19 protein Leu25-Ala177,with an N-terminal Met
Unconjugated
Reconstitute at 100μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin.
Product Suggestions

Product Suggestions

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.